Gansheng Feng
Overview
Explore the profile of Gansheng Feng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Q, Zhou C, Liu J, Xiong B, Zheng C, Feng G
J Interv Med
. 2021 Nov;
1(4):247-251.
PMID: 34805858
To investigate the feasibility and effectiveness of in situ formation of the loop snare technique for retrieval of foreign bodies from vessels. We retrospectively reviewed in situ formation of the...
2.
Liu Y, Ren Y, Ge S, Xiong B, Zhou G, Feng G, et al.
Front Oncol
. 2021 Jun;
11:662408.
PMID: 34155478
Objectives: The purpose of this study was to evaluate the efficacy and safety of transarterial chemoembolization (TACE) in the treatment of patients with treatment-naïve hepatocellular carcinoma (TN-HCC) and recurrent HCC...
3.
Cao Y, Ren Y, Ma H, Zhou C, Liu J, Shi Q, et al.
J Cancer Res Ther
. 2020 Jun;
16(2):356-364.
PMID: 32474524
Objective: This study aimed to classify hepatocellular carcinomas (HCCs) according to their diameter using statistic technology and evaluate the prognosis of the classified groups after the combined use of transarterial...
4.
Liu J, Zhou C, Shi Q, Ma J, Ye T, Zheng C, et al.
Eur J Gastroenterol Hepatol
. 2019 Oct;
32(4):507-516.
PMID: 31658174
Objectives: To explore the candidates, efficacy and safety of interventional therapies in the treatment of portal vein occlusion (PVO). Methods: In our study, 13 patients diagnosed with PVO were included....
5.
Ren Y, Cao Y, Ma H, Kan X, Zhou C, Liu J, et al.
BMC Cancer
. 2019 Oct;
19(1):983.
PMID: 31640620
Background: To determine the safety and efficacy of transarterial chemoembolization (TACE) combined with radiofrequency ablation (hereafter, TACE-RFA) in treating Barcelona Clinic Liver Cancer (BCLC) Stage A or B (hereafter, BCLC...
6.
Liu J, Zhou B, Chen D, Zhou C, Shi Q, Zheng C, et al.
Cardiovasc Intervent Radiol
. 2019 Aug;
42(12):1760-1770.
PMID: 31363898
Purpose: Evaluate the efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) insertion on patients with schistosomiasis-induced liver fibrosis, and compare with that of patients with HBV-induced cirrhosis. Materials And...
7.
Liu J, Shi Q, Xiao S, Zhou C, Zhou B, Yuan F, et al.
J Gastroenterol Hepatol
. 2019 Jun;
35(2):278-283.
PMID: 31222830
Background And Aim: This study aims to evaluate and compare the survival and other portal hypertension-related complications of patients with portal pressure gradient (PPG) ≥ 25 mmHg using transjugular intrahepatic...
8.
Liu Y, Xia X, Wang Y, Li X, Zhou G, Liang H, et al.
Mol Cell Probes
. 2016 Jul;
30(4):246-253.
PMID: 27381416
The biological behaviors of residual hepatoma cells after transarterial embolization therapy, which exist in a hypoxic or even anaerobic tumor microenvironment, differ from the tumor cells under normoxic conditions. This...
9.
Luo S, Song S, Zheng C, Wang Y, Xia X, Liang B, et al.
Evid Based Complement Alternat Med
. 2015 Oct;
2015:840896.
PMID: 26472985
We have prepared Chinese traditional herb Bletilla striata into microspheres as a novel embolic agent for decades. The aim of this study was to evaluate the biocompatibility of Bletilla striata...
10.
Liang B, Chen S, Li L, Liu Y, Xiong F, Dong X, et al.
J Vasc Interv Radiol
. 2015 Aug;
26(12):1879-86.
PMID: 26254117
Purpose: To determine the change in tumor interstitial fluid pressure (IFP) after transcatheter intra-arterial (IA) therapies and its relation to drug penetration in liver cancer. Materials And Methods: VX2 tumors...